← Browse by Condition
Medical Condition

ibd

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for ibd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ibd Clinical Trials

How many clinical trials are currently recruiting for ibd?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for ibd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ibd?
ibd research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ibd clinical trial?
Eligibility criteria for ibd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
University of British Columbia 1 trial
Assistance Publique - Hôpitaux de Paris 1 trial
Children's Hospital Medical Center, Cincinnati 1 trial

Recruiting Clinical Trials

NCT07385807
Recruiting
Exploring Fecal Calprotectin Levels, Maternal and Infant Microbiota, Infant Health, Nutrition, and Adverse Pregnancy Outcomes With Patient With Inflammatory Bowel Disease
Enrollment
80 pts
Location
Canada
Sponsor
University of British Columbia
View Trial →
NCT07300553 Phase 2
Recruiting
Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease
Enrollment
45 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
View Trial →
NCT07195123
Recruiting
Evaluation of the SMART IBD App in Pediatric IBD
Enrollment
70 pts
Location
United States
Sponsor
Children's Hospital Medical Ce...
View Trial →

Related Conditions

ibd inflammatory bowel disease (4) ulcerative colitis uc (2) pregnancy (1) crohn disease (1) inflammatory bowel disease ibd (1) indeterminate colitis (1) crohn disease cd (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology